DAEWOONG PHARMACEUTICAL CO.LTD.
Daewoong
Global Healthcare Group
The Best Partner for You
Global Healthcare Group
The Best Partner for You
Biologics
Making our world healthier together
-
- NABOTA®
- 50, 100, 200Units / vial-Inj.
- Botulinum toxin type A
- Indication
-
- Temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients (Approved in KR, US, EU, Canada)
- Treatment of upper limb spasticity in adult patients (Approved in KR)
- Temporary improvement in the appearance of moderate to severe lateral canthal lines associated with orbicularis oculi activity in adult patients (Approved in KR)
- Treatment of blepharospasm associated with dystonia in adult patients (Approved in KR)
- HI PureTM Technology (KR patent No.13-39349, US Patent No. 9,512,418)
-
- CareTropinTM
- 22.5IU (7.5mg) - Cartridge Pen Type Inj.
- Somatropin (human growth hormone)
- Indication
- Growth hormone replacement therapy in adults with growth hormone deficiency
-
- EposisTM
- 2000, 3000, 4000, 5000, 6000, 8000, 10000IU / Pre-filled syringe Inj.
- rhEPO (recombinant human erythropoietin)
- Indication
- Growth hormone replacement therapy in adults with growth hormone deficiency
-
- EpodionTM
- 2000, 3000, 4000, 10000IU / Pre-filled syringe Inj.
- rhEPO (recombinant human erythropoietin)
- Indication
- Anemia in chronic renal failure
-
- EasyefTM
- 0.5㎎/10㎖ / Topical Solution(Spray)
- rhEGF (=recombinant human Epidermal Growth Factor)
- Indication
- Diabetic foot ulcer